 |
 |
 |
 |
 |
 |
||||
 |
 |
 |
 |
 |
 |
 |
 |
|
Efficacy and Safety Study of Fentanyl Sublingual Spray to Treat Breakthrough Cancer Pain
INS-05-001: A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain www.clinicaltrials.gov listing
INS-06-007: Open-Label Multi-Center Safety Trial of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain www.clinicaltrials.gov listing
NOTICE: The links on this page will take you off the INSYS website. Once you leave the INSYS website, you will be subject to the privacy and security policies of the owners/sponsors of the outside website. INSYS cannot control or guarantee the accuracy, relevance, timeliness or completeness of information contained on a linked website. INSYS does not endorse the organizations sponsoring linked websites, and we do not endorse the views they express or the products/services they offer. INSYS cannot authorize the use of copyrighted materials on linked websites. You will have to request authorization from the sponsor of the linked website. INSYS cannot guarantee that outside websites comply with Section 508 (Accessibility Requirements) of the Rehabilitation Act. INSYS cannot control or guarantee that the owners of other websites will protect your privacy. You should read their privacy policies when you visit other sites.
|
|||||||||
